Recent omics studies have provided a series of biomarkers of systemic inflammation reflecting important physiological roles in lung physiology, among which plasma C-reactive protein (CRP) may participate in the pathogenesis of various pulmonary disorders [54,55]. Here, CRP is linked to lung disorder.